Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glioma
|
353 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.900 | 0.875 | 16 | 2009 | 2020 | |||||
Glaucoma, Open-Angle
|
236 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.810 | 1.000 | 3 | 2011 | 2014 | |||||
Glaucoma
|
198 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.800 | 1.000 | 1 | 2011 | 2011 | |||||
Nasopharyngeal carcinoma
|
320 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.710 | 1.000 | 2 | 2010 | 2016 | |||||
Calcification of coronary artery
|
205 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.700 | 1.000 | 2 | 2011 | 2013 | |||||
Central Nervous System Neoplasms
|
72 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.700 | 1.000 | 2 | 2009 | 2012 | |||||
Nasopharyngeal Neoplasms
|
36 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Glioblastoma
|
281 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.020 | 1.000 | 2 | 2016 | 2020 | |||||
Adenocarcinoma
|
168 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Adult Glioblastoma
|
98 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Adult Medulloblastoma
|
24 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Asthma
|
1536 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Brain Neoplasms
|
204 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1 | 2013 | 2013 | ||||||
Carcinoma of lung
|
1204 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Childhood Glioblastoma
|
98 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Childhood Medulloblastoma
|
25 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Coronary Artery Disease
|
1577 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Glioblastoma Multiforme
|
186 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant neoplasm of lung
|
1142 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Medulloblastoma
|
115 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Myocardial Infarction
|
680 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Piebaldism
|
18 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Primary malignant neoplasm of lung
|
981 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Squamous cell carcinoma
|
257 | 0.683 | 0.440 | 9 | 22068653 | intron variant | G/A | snv | 0.64 | 0.010 | 1.000 | 1 | 2014 | 2014 |